AstraZeneca gets CDSCO Panel Nod to study asthma drug Benralizumab Dr. Divya Colin22 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Zydus Healthcare Gets CDSCO Panel Nod to study Fluticasone, Glycopyrronium, Vilanterol FDC metered dose inhalation Dr. Divya Colin19 Sept 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Nasal Spray Fasedienol Provides Rapid Social Anxiety Benefit in Phase 3 Tria Dr. Shravani Dali11 Aug 2023 8:00 PM ISTAccording to biopharmaceutical company Vistagen an investigative nasal spray designed to treat social anxiety disorder (SAD) achieved late-stage...
Roche Gets CDSCO Nod To Study Anticancer FDC Drug Dr. Divya Colin25 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Twice-daily lotilaner ophthalmic solution effective treatment of patients with Demodex blepharitis Dr. Shravani Dali26 Jun 2023 8:00 PM ISTTwice-daily treatment with lotilaner ophthalmic solution,holds promise for the effective treatment of patients with Demodex blepharitis suggests a new...
IQVIA gets CDSCO panel Nod To Study ABX464 Dr. Divya Colin8 May 2023 5:30 PM ISTNew Delhi: The leading global contract research organization, IQVIA has got the green signal from the Subject Expert Committee(SEC) functional under...
Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan Dr. Divya Colin15 April 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy's Laboratories, the Subject Expert...
CDSCO panel approves Reliance Life Science's Phase III CT Protocol for Tocilizumab Dr. Divya Colin9 April 2023 5:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Reliance Life...
Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 6:00 PM ISTNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
Submit adequate justification: CDSCO Panel tells Synokem pharma about Phase III CT of Naftifine Cream Dr. Divya Colin26 Oct 2022 11:45 AM ISTNew Delhi: Regarding the ongoing Phase III Clinical trial with the drug Naftifine HCI Cream 2%w/w, the Subject Expert Committee (SEC) functional under...
Synokem Pharma Gets CDSCO Panel nod to study Anti Allergic Combination Drug Dr. Divya Colin15 Oct 2022 6:00 PM ISTNew Delhi: Synokem Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
